Index of /pharmacovigilance/


NameSizeDateMIME Type
../-Aug 19, 2021 09:44:27Directory
2021 04 17 courrier PELE DAJR_2021042000157 S.pdf832.67 KBAug 09, 2021 19:31:07application/pdf
ANNEXES - Abbréviations Line listing_v2.pdf273.72 KBAug 10, 2021 20:34:15application/pdf
articles_codes_base_nationale_pharmacovigilance.txt0.94 KBAug 19, 2021 09:44:27text/plain
Explication_codes_C_B_S_Méthode française d’imputabilité médicamenteuse, dite méthode Bégaud _ Centre Régional de Pharmacovigilance du Nord-Pas-de-Calais.pdf578.14 KBAug 10, 2021 22:28:25application/pdf
point_1_signed_declaration_101578_charabianibagheri_haleh_20210315.pdf112.39 KBAug 09, 2021 19:35:45application/pdf
point_1_signed_declaration_102133_cottin_judith_20210329(3).pdf113.64 KBAug 09, 2021 19:35:46application/pdf
point_1_signed_declaration_102138_alttebacher_martine_20210329.pdf112.53 KBAug 09, 2021 19:35:46application/pdf
point_1_signed_declaration_103560_massyguillemant_nathalie_20210429.pdf112.83 KBAug 09, 2021 19:35:46application/pdf
point_1_signed_declaration_103656_micallefroll_joelle_20210430.pdf114.65 KBAug 09, 2021 19:35:46application/pdf
point_1_signed_declaration_94736_lepelley_marion_20201102.pdf111.70 KBAug 09, 2021 19:35:46application/pdf
point_1_signed_declaration_95206_pariente_antoine_20201110.pdf117.49 KBAug 09, 2021 19:35:47application/pdf
point_1_signed_declaration_95868_gautier_sophie_20201124.pdf112.50 KBAug 09, 2021 19:35:47application/pdf
point_1_signed_declaration_95955_valnetrabier_marieblanche_20201125.pdf111.91 KBAug 09, 2021 19:35:47application/pdf
point_1_signed_declaration_95993_lacroix_isabelle_20210429.pdf112.76 KBAug 09, 2021 19:35:47application/pdf
point_1_signed_declaration_96192_graschampel_valerie_20201201.pdf112.03 KBAug 09, 2021 19:35:47application/pdf
point_1_signed_declaration_96464_atzenhoffer_marina_20201205.pdf112.34 KBAug 09, 2021 19:35:47application/pdf
point_1_signed_declaration_97247_salvo_ciccio_20201221.pdf113.70 KBAug 09, 2021 19:35:47application/pdf
points_3_et_4_20210618 - VACCIN ASTRAZENECA - CADA.pdf3.63 MBAug 09, 2021 19:36:30application/pdf
points_3_et_4_20210618 - VACCIN COMIRNATY - CADA.pdf5.35 MBAug 09, 2021 19:36:30application/pdf
points_3_et_4_20210618 - VACCIN MODERNA - CADA.pdf981.96 KBAug 09, 2021 19:36:30application/pdf
points_3_et_4_ASTRAZENECA_CasMarquants_20210624.pdf41.90 KBAug 09, 2021 19:36:18application/pdf
points_3_et_4_COMIRNATY_CasMarquants_20210624.pdf54.82 KBAug 09, 2021 19:36:17application/pdf
points_3_et_4_MODERNA_CasMarquants_20210624.pdf33.58 KBAug 09, 2021 19:36:17application/pdf
reponse_ansm_demande_cada_06082021_recue_09082021_1V152.pdf842.21 KBAug 09, 2021 19:29:54application/pdf
resume_Réactualisation de la méthode française d’imputabilité des effets indésirables des médicaments _ Thérapie.pdf211.76 KBAug 10, 2021 22:20:21application/pdf
Yannick A et al., Updating the French Method for the Causality Assessment of Adverse Drug Reactions, Therapie 2013_JCEMethodelogistique.pdf250.45 KBAug 10, 2021 22:20:21application/pdf


Powered by Abyss Web Server X2
Copyright © Aprelium - 2001-2022